Digestive & Intestinal Remedies (Pharmacies) - Gambia

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$470.30k in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.68%, resulting in a market volume of US$620.00k by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$0.17 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Gambia is experiencing significant growth due to changing customer preferences and trends in the market. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Gambia are shifting towards natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are seeking alternatives to traditional pharmaceuticals. This preference for natural remedies is driven by a desire for a more holistic approach to healthcare and a growing awareness of the potential side effects of synthetic medications. As a result, there is an increasing demand for herbal supplements and digestive aids in the market. Trends in the market indicate a growing focus on preventative healthcare. Consumers are taking a proactive approach to managing their digestive and intestinal health, seeking products that can help prevent issues such as indigestion, bloating, and constipation. This trend is driven by a desire to maintain overall wellness and prevent the need for more serious medical intervention in the future. As a result, there is a growing market for products that promote digestive health and support a healthy gut microbiome. In addition to changing customer preferences, there are also local special circumstances that are contributing to the development of the Digestive & Intestinal Remedies (Pharmacies) market in Gambia. One such circumstance is the prevalence of traditional medicine practices in the country. Traditional medicine has a long history in Gambia and is deeply ingrained in the culture. Many Gambians still rely on traditional remedies for digestive and intestinal issues, and this has created a unique market for both traditional and modern remedies. Underlying macroeconomic factors are also playing a role in the development of the Digestive & Intestinal Remedies (Pharmacies) market in Gambia. The country has experienced steady economic growth in recent years, leading to an increase in disposable income and a growing middle class. This has resulted in greater purchasing power and an increased demand for healthcare products, including digestive and intestinal remedies. Additionally, the government has been investing in healthcare infrastructure and promoting the use of pharmaceuticals, further driving market growth. Overall, the Digestive & Intestinal Remedies (Pharmacies) market in Gambia is developing in response to changing customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. As consumers increasingly seek natural and preventative healthcare solutions, the market is likely to continue to grow and evolve to meet these demands.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.